Skyrizi 150 MG/ML penml
Ended Awarded Last action
- Contract number
- SPE2DR26FMJ6D
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,321
Award facts
- Contract value 100% obligated
- $15,320.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $15,320.93 to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml pen/ml on December 23, 2025, with completion scheduled for December 24, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. SKYRIZI is a specialty pharmaceutical product, and this order fulfills AmerisourceBergen's supply obligations under the broader DLA pharmaceutical prime vendor agreement, which enables the company to supply a comprehensive range of medications and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally. The award reflects the company's demonstrated capability to meet federal procurement requirements through open competition and its role as a strategic supplier within the DLA's pharmaceutical support infrastructure.
Quick answers
Who was awarded contract SPE2DR26FMJ6D?
SPE2DR26FMJ6D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 23, 2025.
How much is contract SPE2DR26FMJ6D worth?
The government has obligated $15,321 on SPE2DR26FMJ6D.
Is contract SPE2DR26FMJ6D an order under another contract?
Yes. SPE2DR26FMJ6D is a delivery order under SPE2DR25D1200, an indefinite delivery contract.
Was contract SPE2DR26FMJ6D competed?
The extent of competition for SPE2DR26FMJ6D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award